Medipharm Labs Corp Stock Market Value

LABS Stock  CAD 0.07  0.01  7.14%   
Medipharm Labs' market value is the price at which a share of Medipharm Labs trades on a public exchange. It measures the collective expectations of Medipharm Labs Corp investors about its performance. Medipharm Labs is selling at 0.065 as of the 28th of November 2024; that is 7.14% down since the beginning of the trading day. The stock's open price was 0.07.
With this module, you can estimate the performance of a buy and hold strategy of Medipharm Labs Corp and determine expected loss or profit from investing in Medipharm Labs over a given investment horizon. Check out Medipharm Labs Correlation, Medipharm Labs Volatility and Medipharm Labs Alpha and Beta module to complement your research on Medipharm Labs.
Symbol

Medipharm Labs Corp Price To Book Ratio

Please note, there is a significant difference between Medipharm Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medipharm Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medipharm Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medipharm Labs 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medipharm Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medipharm Labs.
0.00
10/29/2024
No Change 0.00  0.0 
In 31 days
11/28/2024
0.00
If you would invest  0.00  in Medipharm Labs on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Medipharm Labs Corp or generate 0.0% return on investment in Medipharm Labs over 30 days. Medipharm Labs is related to or competes with OrganiGram Holdings, and Charlottes Web. MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentra... More

Medipharm Labs Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medipharm Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medipharm Labs Corp upside and downside potential and time the market with a certain degree of confidence.

Medipharm Labs Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Medipharm Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medipharm Labs' standard deviation. In reality, there are many statistical measures that can use Medipharm Labs historical prices to predict the future Medipharm Labs' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.075.53
Details
Intrinsic
Valuation
LowRealHigh
0.000.065.52
Details
Naive
Forecast
LowNextHigh
00.075.52
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Medipharm Labs Corp Backtested Returns

As of now, Medipharm Stock is out of control. Medipharm Labs Corp has Sharpe Ratio of 0.0048, which conveys that the firm had a 0.0048% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Medipharm Labs, which you can use to evaluate the volatility of the firm. Please verify Medipharm Labs' Risk Adjusted Performance of 0.0143, downside deviation of 7.71, and Mean Deviation of 3.85 to check out if the risk estimate we provide is consistent with the expected return of 0.0263%. The company secures a Beta (Market Risk) of 1.17, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Medipharm Labs will likely underperform. Medipharm Labs Corp right now secures a risk of 5.46%. Please verify Medipharm Labs Corp coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if Medipharm Labs Corp will be following its current price movements.

Auto-correlation

    
  0.47  

Average predictability

Medipharm Labs Corp has average predictability. Overlapping area represents the amount of predictability between Medipharm Labs time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medipharm Labs Corp price movement. The serial correlation of 0.47 indicates that about 47.0% of current Medipharm Labs price fluctuation can be explain by its past prices.
Correlation Coefficient0.47
Spearman Rank Test-0.45
Residual Average0.0
Price Variance0.0

Medipharm Labs Corp lagged returns against current returns

Autocorrelation, which is Medipharm Labs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medipharm Labs' stock expected returns. We can calculate the autocorrelation of Medipharm Labs returns to help us make a trade decision. For example, suppose you find that Medipharm Labs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Medipharm Labs regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medipharm Labs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medipharm Labs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medipharm Labs stock over time.
   Current vs Lagged Prices   
       Timeline  

Medipharm Labs Lagged Returns

When evaluating Medipharm Labs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medipharm Labs stock have on its future price. Medipharm Labs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medipharm Labs autocorrelation shows the relationship between Medipharm Labs stock current value and its past values and can show if there is a momentum factor associated with investing in Medipharm Labs Corp.
   Regressed Prices   
       Timeline  

Pair Trading with Medipharm Labs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medipharm Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Medipharm Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medipharm Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medipharm Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medipharm Labs Corp to buy it.
The correlation of Medipharm Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medipharm Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medipharm Labs Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medipharm Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Medipharm Stock

Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.